Bradford S Goodwin

CIK 1293633 · Chairperson of the Board · last filed 2021-05-21

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.19M

Companies

4

Total Filings

39

Lifetime Open-Market Net

$99.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RIGL Director 35,000 $32.85 $1.15M $99.3K 16 2021-05-21
FACT Director 3,334 $10.65 $35.5K $0 3 2010-04-21
PDL BIOPHARMA, INC. (PDLI) Delisted Chairperson of the Board $0 6 2008-07-17
COTHERIX INC (CTRX) Delisted Director 0 $0 2 2007-01-10

Recent Filings · Page 3 of 4

39 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2010-05-28 RIGL Grant (A) $0 EDGAR
2010-04-23 Disp (D) −3,334 -$90.0K
2010-04-21 FACT U −10,000 -$270.0K EDGAR
2009-08-24 Grant (A) $0
2009-05-29 RIGL Grant (A) $0 EDGAR
2009-05-28 FACT Grant (A) +3,334 $0 EDGAR
2009-01-27 FACT Grant (A) +10,000 $0 EDGAR
2008-07-17 PDL BIOPHARMA, INC. (PDLI) Delisted Grant (A) $0 EDGAR
2008-05-30 PDL BIOPHARMA, INC. (PDLI) Delisted Grant (A) $0 EDGAR
2008-05-30 RIGL Grant (A) $0 EDGAR
Showing 2130 of 39
Page 3 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.